MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway-Reference-Cited by-同舟云学术

MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway

Published:2016-11 Issue:1 Volume:593 Page:84-90
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Shen Hongyu,Li Liangpeng,Yang Sujin,Wang Dandan,Zhong Shanliang,Zhao Jianhua,Tang Jinhai

Funder

National High Technology Research and Development Program of China

National Natural Science Foundation of China

National key clinical specialist construction Programs of China

Major Program of Natural Science Foundation of Jiangsu Province

Natural Science Foundation of Jiangsu Province

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference31 articles.

1. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN;Chun-Zhi;BMC Cancer,2010

2. MicroRNA-221 Targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway;Du;Tumour Biol.,2015

3. Post-transcriptional regulation of cadherin-11 expression by GSK-3 and beta-catenin in prostate and breast cancer cells;Farina;PLoS One,2009

4. Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells;Fu;FEBS Lett.,2012

5. Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance;Galimov;J. Mol. Med. (Berl),2015

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view;Functional & Integrative Genomics;2024-09-02

2. Mechanistic and therapeutic perspectives of miRNA-PTEN signaling axis in cancer therapy resistance;Biochemical Pharmacology;2024-08

3. Potential roles of the exosome/microRNA axis in breast cancer;Pathology - Research and Practice;2023-11

4. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming;Molecular Aspects of Medicine;2023-10

5. Breast cancer: miRNAs monitoring chemoresistance and systemic therapy;Frontiers in Oncology;2023-06-16